This study investigates the feasibility and safety of remimazolam for patient-controlled sedation in outpatient colonoscopy procedures.
Conducted a pilot study involving outpatient colonoscopy procedures
Utilized remimazolam for sedation controlled by patients
Assessed patient satisfaction and safety outcomes
Remimazolam sedation was found to be feasible and safe for colonoscopy
Patients reported high levels of satisfaction with the sedation method
No major adverse effects were noted during the pilot study
Abstract
Remimazolam PCS appears feasible, safe, and well tolerated for colonoscopy, with high patient satisfaction. Larger studies are warranted to confirm these findings and optimize dosing strategies. .